Wikidata

(Q34881233)

English

An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

scientific article

In more languages

Statements

title
An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19011431
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19011431%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 January 2020
main subject
patient
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q34881233&oldid=1836205266"